Editorial
New surgical strategies from endoscopical resection to liver transplantation for hepatobiliopancreatic tumours
Chinese Clinical Oncology
2024;
13
(2)
:18
.
(30 April 2024)
Original Article
Anaerobic gram-negative rod bacteremia as a marker of gastrointestinal cancer in Japanese patients: a single-center retrospective study
Chinese Clinical Oncology
2024;
13
(2)
:19
.
(30 April 2024)
Intralesional curettage and surgical adjuvants in the treatment of giant cell tumor of bone: meta-analysis and systematic review
Chinese Clinical Oncology
2024;
13
(2)
:20
.
(30 April 2024)
Stepwise analysis of thyroid diagnostic modalities with genomic imprinting detection
Chinese Clinical Oncology
2024;
13
(2)
:21
.
(30 April 2024)
Adjuvant radiotherapy versus observation after gross total resection of WHO grade II ependymoma: a systematic review and individual-participant data meta-analysis
Chinese Clinical Oncology
2024;
13
(2)
:22
.
(30 April 2024)
Review Article
Narrative review of the utility of magnetic resonance imaging in radiotherapy for cervical cancer
Chinese Clinical Oncology
2024;
13
(2)
:23
.
(30 April 2024)
Advancements and future directions in positron emission tomography-guided radiotherapy: a narrative review
Chinese Clinical Oncology
2024;
13
(2)
:24
.
(30 April 2024)
Treatment strategies for borderline resectable pancreatic neuroendocrine tumors: a narrative review
Chinese Clinical Oncology
2024;
13
(2)
:25
.
(30 April 2024)
Clinical status and perspective on the application of immunotherapy combined with chemotherapy in advanced non-small cell lung cancer: a review
Chinese Clinical Oncology
2024;
13
(2)
:26
.
(30 April 2024)
Editorial Commentary
Triplet therapy for metastatic hormone sensitive prostate cancer—looking beyond volume of disease
Chinese Clinical Oncology
2024;
13
(2)
:27
.
(30 April 2024)
Oligometastatic disease: a need for consensus to cure the incurable in a multidisciplinary approach
Chinese Clinical Oncology
2024;
13
(2)
:28
.
(30 April 2024)
Radiation-free conditioning in acute lymphoblastic leukemia: is it time?
Chinese Clinical Oncology
2024;
13
(2)
:29
.
(30 April 2024)
Ad(aura): a fresh breeze for patients with resected EGFR-mutant non-small cell lung cancer
Chinese Clinical Oncology
2024;
13
(2)
:30
.
(30 April 2024)
CAR-T cell therapy: unravelling its potential in extra-nodal diffuse large B cell lymphoma
Chinese Clinical Oncology
2024;
13
(2)
:31
.
(30 April 2024)
